Irked by a pharma CEOs broken promise? We are making a list

Biotech and pharma CEOs are used to having their words recorded. Whether its at an investor conference, an industry confab, a press conference or a quarterly earnings call, CEO statements end up everywhere from webcasts to reporters notebooks. Sometimes, those statements arent just facts. They are pledges of one kind or another. And while executives often hold true to their public statements, sometimes they just dont. This fall, we are planning to highlight the biggest promises made and broken by biopharma execs in recent years and we are turning to readers to help compile the list. Be it a promise not to raise prices or settle a lawsuit, a promise to hit a particular long-term sales target, a promise not to sell a company, unforeseen layoffs, misleading M&A comments or more, we want to hear your ideas for the upcoming feature. Anytime a pharma CEO said one thing and did another, that’s worth noting. We’ll plan to highlight a group of the broken promises in a special report this October. Please share your ideas in this form. Nominations are open until Aug. 30. Questions in the meantime? Feel free to get in touch through email or Twitter.